Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Viridian Therapeutics (VRDN) has a market cap of $1.04 billion USD. According to our data, Viridian Therapeutics is ranked No.4991 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.04 B |
-31.31%
|
| Dec 31, 2024 | $1.52 B |
-11.98%
|
| Dec 29, 2023 | $1.73 B |
-25.44%
|
| Dec 30, 2022 | $2.31 B |
47.75%
|
| Dec 31, 2021 | $1.57 B |
20.18%
|
| Dec 31, 2020 | $1.30 B |
128.47%
|
| Dec 31, 2019 | $0.57 B |
-84.16%
|
| Dec 31, 2018 | $3.60 B |
-70.95%
|
| Dec 29, 2017 | $12.39 B |
108.18%
|
| Dec 30, 2016 | $5.95 B |
-55.35%
|
| Dec 31, 2015 | $13.33 B |
-70.55%
|
| Dec 31, 2014 | $45.27 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
| Market Cap | = | VRDN Stock Price | * | VRDN Shares Outstanding |
| = | $12.80 | * | 81.49 M | |
| = | $1.04 B |